deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT03269409

Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis

Double Blind, Phase I, Randomized, Parallel Group Study of Hip Decompression Compared to Hip Decompression Supplemented at the Point of Care With Adipose Derived Regenerative Cells for Bilateral Pre-Collapse Femoral Head Osteonecrosis

Sponsor: Mayo Clinic

Conditions Osteonecrosis
Interventions Adipose Derived Regenerative Cells (ADRC) Lactated Ringers The Celution 800/GP System (Cytori Therapeutics)
Updated 16 times since 2017 Last updated: Dec 21, 2021 Started: Nov 15, 2017 Primary completion: Jun 28, 2021 Completion: Jun 28, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Logistical delays from device manufacturer due to COVID

Other terminated trials from Mayo Clinic

See all terminations from Mayo Clinic

Other Osteonecrosis trials with similar outcome

Browse all Osteonecrosis trials

This PHASE1 trial investigates Osteonecrosis and is currently terminated or withdrawn. Mayo Clinic leads this study, which shows 16 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Sep 2019 · 9 months · monthly snapshot~Sep 2019 – ~Jan 2020 · 4 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Feb 2022 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Suspended → Terminated

  4. Sep 2021 — Feb 2022 [monthly]

    Suspended PHASE1

  5. Apr 2021 — Sep 2021 [monthly]

    Suspended PHASE1

▶ Show 11 earlier versions

  1. Jan 2021 — Apr 2021 [monthly]

    Suspended PHASE1

  2. Apr 2020 — Jan 2021 [monthly]

    Suspended PHASE1

    Status: Recruiting → Suspended

  3. Feb 2020 — Apr 2020 [monthly]

    Recruiting PHASE1

  4. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE1

    Phase: NA → PHASE1

  5. Sep 2019 — Jan 2020 [monthly]

    Recruiting NA

  6. Dec 2018 — Sep 2019 [monthly]

    Recruiting NA

  7. Aug 2018 — Dec 2018 [monthly]

    Recruiting NA

  8. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  9. Jan 2018 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Dec 2017 — Jan 2018 [monthly]

    Not Yet Recruiting NA

  11. Sep 2017 — Dec 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations